Survey finds Europe top alternative for Chinese life science investors amid CFIUS concerns

A survey of Chinese investors revealed broad concern about U.S. restrictions on foreign investment in the life sciences that is diverting Chinese investments to other countries, with Europe cited as the top alternative for investment.

Sixty percent of respondents said they and their peers are “much less active” in China-to-U.S.

Read the full 496 word article

User Sign In